Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Geron Corp (NASDAQ:GERN)

2.06
Delayed Data
As of 3:59pm ET
 -0.02 / -0.96%
Today’s Change
1.81
Today|||52-Week Range
3.15
-0.48%
Year-to-Date
No recent news for Geron Corp.

Today’s Trading

Previous close2.08
Today’s open2.07
Day’s range2.04 - 2.10
Volume977,109
Average volume (3 months)1,030,196
Market cap$331.2M
Dividend yield--
Data as of 3:59pm ET, 10/19/2017

Growth & Valuation

Earnings growth (last year)-63,433.33%
Earnings growth (this year)--
Earnings growth (next 5 years)--
Revenue growth (last year)-83.06%
P/E ratioNM
Price/Sales53.43
Price/Book2.71

Competitors

 Today’s
change
Today’s
% change
BTXBioTime Inc+0.04+1.49%
BLCMBellicum Pharmaceuti...-0.10-0.96%
EDGEEdge Therapeutics In...+0.06+0.59%
AGENAgenus Inc-0.24-5.10%
Data as of 7:59pm ET, 10/19/2017

Financials

Next reporting dateNovember 9, 2017
EPS forecast (this quarter)-$0.05
Annual revenue (last year)$6.2M
Annual profit (last year)-$29.5M
Net profit margin-479.34%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
John A. Scarlett
Chief Financial Officer, Treasurer &
Executive VP
Olivia K. Bloom
Corporate headquarters
Menlo Park, California

Forecasts